RPTX

RPTX

USD

Repare Therapeutics Inc. Common Shares

$1.780-0.040 (-2.198%)

Echtzeitkurs

Healthcare
Biotechnologie
Kanada

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.820

Hoch

$1.855

Tief

$1.780

Volumen

0.15M

Unternehmensfundamentaldaten

Marktkapitalisierung

76.5M

Branche

Biotechnologie

Land

Canada

Handelsstatistiken

Durchschnittliches Volumen

0.13M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $0.89Aktuell $1.780Hoch $4.069

Ähnliche Nachrichten

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.

Mehr anzeigen
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.

Mehr anzeigen
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
BusinessWire

Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a clinical-stage precision oncology company, today announced it will share initial topline safety, tolerability and early efficacy data from the Phase

Mehr anzeigen
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics